Why GlaxoSmithKline is lying…
Yesterday, I blogged about GlaxoSmithKline’s (GSK) new program to reduce the prices of most of its medicines (see related story) . I strongly believe that the campaign is just a pathetic attempt to save GSK’s bottom line and the company doesn’t really want to help the Filipino people have access to quality but affordable medicines.
And it seems that I am right. On the same day that GSK’s ad appeared in the Philippine Daily Inquirer, a related story appeared in Business World (see full story). This is the first few paragraphs of the article entitled “US lobby wants RP penalized for cheaper drugs law:”
American pharmaceutical firms have asked the US government to punish the Philippines by imposing trade barriers, claiming the new Cheaper Medicines Law violates international rules on patents.
The Pharmaucetical Research and Manufacturers of America (PhRMA) put the country on top of its list of intellectual property rights violators, outranking Thailand and called on the Obama administration to add the Philippines to an annual list of “priority” states deemed inefficient in upholding intellectual property rights.
So I Googled PhRMA and tried to find out who are the members of this group. In its website, it stated that GSK is one of PhRMA members. Wow, did you get the irony?! Here is GSK Philippines, trumpeting to the entire country that it is reducing prices because it wants to make quality medicines affordable to Filipinos. On the other hand, its mother company in the US is part of the group lobbying the Obama administration to punish us. There’s a clear disconnect here.
If GSK Philippines is sincere and committed to protect the health of Filipinos, then what the heck is its mother company doing? Two-faced is how I see it.